Skip to main content
Clinical Trials/NL-OMON31517
NL-OMON31517RecruitingPhase 4

Wet-wrap treatment in children with atopic eczema using the wet-wrap method with diluted corticosteroids versus emollients - Wet Wrap study

Havenziekenhuis0 sites40 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
2 to 11 (—)

Inclusion Criteria

  • Age 6 months- 6 years at inclusion
  • Diagnosis of atopic eczema with an objective SCORAD >= 40
  • Parent/legal guardian willing to comply with the protocol
  • Written, dated consent for subject to participate

Exclusion Criteria

  • Known pre-existing, serious underlying disease
  • (secondary) infected eczema:
  • oIn case of overt impetiginisation, wet wrapping should be delayed until 48-72 hours after commencing antibiotics and confirmation of appropriate treatment by skin swab results.
  • oEczema herpeticum is an absolute contraindication for the use of wet dressings.
  • Signs and symptoms of systemic infection (such as fever, defined as a temperature equivalent to a rectal temperature greater than 38.3ºC).
  • Problems in the hypothalamus-pituitary-adrenal axis (HPA)
  • Systemic corticosteroid therapy
  • Severe growth retardation

Investigators

Sponsor
Havenziekenhuis

Similar Trials